Search Results
131 items found for "Metabolomic alterations"
- Ep 154 with Dr Badr Sokrat
Badr Sokrat " After completing my undergraduate studies with an internship in the laboratory of Dr. Research Yamina and Badr discussed Badr’s career trajectory and his decision to pursue a postdoc abroad after He highlighted that he had to regain his confidence after a period of three failed experiments. Yamina advised him to consider career options after his postdoc and adapt to different systems.
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Van Meir’s research examines how genetic alterations and hypoxia induce changes in cell biology that
- Logo Contest for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
The contest deadline is August 15th, 2024, 11:59 PM CST (designs received after the deadline will not
- Dr. GPCR Summit 2021 | Dr. GPCR Ecosystem
Alternatively, you can provide us with the embed code to make your presentation available during the
- Ep 88 with Dr. Hannes Schihada
After my Ph.D. defense in 2019, I moved with a DFG (German research council) PostDoc fellowship to Stockholm
- Ep 19 with Dr. Fiona Marshall
Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture
- Ep 64 with Dylan Eiger
After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and
- Ep 136 with Murat Tunaboylu & Ben Holland
After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer
- A journey from Duke to McGill along the dopamine circuit
After a doctoral training at the Pierre and Marie Curie University in Paris and a short internship at
- Ep 114 with Dr. Robert F. Bruns
After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then
- Ep 65 with Dr. Sudarshan Rajagopal
After completing his training in clinical cardiology, he started as an Assistant Professor of Medicine
- Ep 32 with Dr. Chris Tate
After obtaining a research fellowship at Girton College (Cambridge) he moved to the LMB in 1992 to work Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by
- Ep 90 with Dr. Nariman Balenga
Waldhoer at the Medical University of Graz, Austria, and received my Ph.D. in Molecular Medicine in 2010 after
- Legal Policies and Disclaimers | Dr. GPCR Ecosystem
The revised terms and conditions will become effective upon posting and if you use the Service after
- GPCR Retreat Registration 2023 | Dr. GPCR Ecosystem
Registration Deadline is September 21 (note that an extra CAD$ 100 will be added to the registration fee after
- Applying Pharmacology to Drug Discovery
Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta,
- Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
After completing his training, he joined the faculty at Duke, with a focus on the mechanisms underlying
- [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts]
under 1 mg/L LPS-induced GFs inflammatory state were evaluated by RT-qPCR and Western blotting analysis after interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF)-α, prostaglandin endoperoxide synthase 2 (PTGS2) after
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
We quantified the kinetic antagonism between chemokines and hCCR3 before and after adding hCCR3 antagonists Orozco , Siobán B Keel , Paul C Hendrie , Bart L Scott , M Cristina Ghiuzeli , Elihu H Estey , Roland B Walter
- Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report
increase of between 10 and 35 points in the Short-Form 36 Physical Function (SF36-PF) at week four after
- Ep 87 with Dr. Bianca Plouffe
After obtaining a Postdoctoral Fellowship from the Canadian Institutes of Health Research in 2012, Bianca
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
After completing his medical studies at George Washington University, the NIH and UCLA, he pursued his
- Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation
personalised GPCR-targeted nanomedicines, for the delivery of lethal drugs to tumour tissue before, during and after
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
She obtained her Ph.D. from UFMG in 2006 and, after that, she performed her postdoctorate studies at
- Principles of Pharmacology in Drug Discovery I
Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta,
- Ep 106 with Dr. Bruno Giros
After doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
lungs with induced fibrosis, eight GPCRs were identified, showing a >2-fold increase in mRNA expression after
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
threonine kinase Akt at Ser473 and Thr308, in contrast with the phosphorylation of Akt only at Ser473 after